Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.

Marchaim D, Pogue JM, Tzuman O, Hayakawa K, Lephart PR, Salimnia H, Painter T, Zervos MJ, Johnson LE, Perri MB, Hartman P, Thyagarajan RV, Major S, Goodell M, Fakih MG, Washer LL, Newton DW, Malani AN, Wholehan JM, Mody L, Kaye KS.

J Clin Microbiol. 2014 May;52(5):1617-21. doi: 10.1128/JCM.00001-14. Epub 2014 Mar 5.

PMID:
24599978
[PubMed - in process]
2.

In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest.

Pillar CM, Draghi DC, Dowzicky MJ, Sahm DF.

J Clin Microbiol. 2008 Sep;46(9):2862-7. doi: 10.1128/JCM.00637-08. Epub 2008 Jul 2.

PMID:
18596149
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.

Chen YH, Lu PL, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR.

Antimicrob Agents Chemother. 2012 Mar;56(3):1452-7. doi: 10.1128/AAC.06053-11. Epub 2011 Dec 27.

PMID:
22203598
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010.

Liu JW, Ko WC, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Chen YH, Lu PL, Sun W, Wang LS, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR.

Antimicrob Agents Chemother. 2012 Mar;56(3):1414-7. doi: 10.1128/AAC.05879-11. Epub 2011 Dec 12.

PMID:
22155819
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.

Casal M, Rodríguez F, Johnson B, Garduno E, Tubau F, de Lejarazu RO, Tenorio A, Giménez MJ, Bartolomé R, Garcia-Rey C, Aguilar L, García-Escribano N.

J Antimicrob Chemother. 2009 Jul;64(1):69-72. doi: 10.1093/jac/dkp169. Epub 2009 May 17.

PMID:
19451133
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.

Zarkotou O, Pournaras S, Altouvas G, Pitiriga V, Tziraki M, Mamali V, Themeli-Digalaki K, Tsakris A.

J Clin Microbiol. 2012 Nov;50(11):3747-50. doi: 10.1128/JCM.02037-12. Epub 2012 Aug 29.

PMID:
22933593
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.

Fernández-Canigia L, Dowzicky MJ.

Ann Clin Microbiol Antimicrob. 2012 Oct 22;11:29. doi: 10.1186/1476-0711-11-29.

PMID:
23088592
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Lu CT, Chuang YC, Sun W, Liu YC, Cheng YJ, Lu PL, Chen CM, Hsu GJ, Jang TN, Lee CM, Chiang PC, Shi ZY, Wang LS, Kung HC, Lin HC, Liao CH, Liu JW, Huang CH, Tsao SM, Hsueh PR.

Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S179-83. doi: 10.1016/S0924-8579(08)70024-4.

PMID:
19013351
[PubMed - indexed for MEDLINE]
10.

Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.

Kulah C, Aktas E, Comert F, Ozlu N, Akyar I, Ankarali H.

BMC Infect Dis. 2009 Mar 16;9:30. doi: 10.1186/1471-2334-9-30.

PMID:
19291298
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline.

Huang TD, Berhin C, Bogaerts P, Glupczynski Y.

J Antimicrob Chemother. 2012 Nov;67(11):2696-9. doi: 10.1093/jac/dks288. Epub 2012 Jul 24.

PMID:
22833638
[PubMed - indexed for MEDLINE]
Free Article
13.

Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).

Sader HS, Farrell DJ, Jones RN.

Diagn Microbiol Infect Dis. 2011 Feb;69(2):223-7. doi: 10.1016/j.diagmicrobio.2010.10.020.

PMID:
21251571
[PubMed - indexed for MEDLINE]
14.

In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa.

Ahmed NH, Baba K, Clay C, Lekalakala R, Hoosen AA.

BMC Res Notes. 2012 May 3;5:215. doi: 10.1186/1756-0500-5-215.

PMID:
22554305
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

Navon-Venezia S, Leavitt A, Carmeli Y.

J Antimicrob Chemother. 2007 Apr;59(4):772-4. Epub 2007 Mar 12.

PMID:
17353223
[PubMed - indexed for MEDLINE]
Free Article
16.

In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.

Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Chuang YC, Lin HC, Shi ZY, Kung HC, Huang CH, Tsao SM, Lu CT, Liao CH, Hsueh PR.

Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S188-91. doi: 10.1016/S0924-8579(08)70026-8.

PMID:
19013353
[PubMed - indexed for MEDLINE]
17.

In vitro activities of nine current antibiotics against culprit bacteria in nosocomial infections in an institution in Northern Taiwan.

Lee SC, Huang SS, See LC, Tsai MH, Shieh WB.

Chang Gung Med J. 2011 Nov-Dec;34(6):580-9.

PMID:
22196060
[PubMed - indexed for MEDLINE]
Free Article
18.

In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.

Kanj SS, Whitelaw A, Dowzicky MJ.

Int J Antimicrob Agents. 2014 Feb;43(2):170-8. doi: 10.1016/j.ijantimicag.2013.10.011. Epub 2013 Nov 15.

PMID:
24315313
[PubMed - in process]
19.

Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.

Markelz AE, Mende K, Murray CK, Yu X, Zera WC, Hospenthal DR, Beckius ML, Calvano T, Akers KS.

Antimicrob Agents Chemother. 2011 Oct;55(10):4707-11. doi: 10.1128/AAC.00112-11. Epub 2011 Aug 1. Erratum in: Antimicrob Agents Chemother. 2012 Feb;56(2):1149.

PMID:
21807971
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk